Millennium Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-165,659
| Closed | -$4.47M | – | 7305 |
|
|
2022
Q4 | $4.47M | Buy |
165,659
+152,094
| +1,121% | +$4M | ﹤0.01% | 2912 |
|
|
2022
Q3 | $244K | Sell |
13,565
-251,823
| -95% | -$4.02M | ﹤0.01% | 5521 |
|
|
2022
Q2 | $3.3M | Buy |
265,388
+201,362
| +315% | +$2.22M | ﹤0.01% | 3207 |
|
|
2022
Q1 | $853K | Sell |
64,026
-54,251
| -46% | -$727K | ﹤0.01% | 4678 |
|
|
2021
Q4 | $1.84M | Sell |
118,277
-65,622
| -36% | -$1.25M | ﹤0.01% | 3854 |
|
|
2021
Q3 | $4.13M | Sell |
183,899
-35,560
| -16% | -$781K | ﹤0.01% | 3095 |
|
|
2021
Q2 | $5M | Buy |
+219,459
| New | +$4.62M | ﹤0.01% | 2758 |
|
|
2021
Q1 | – | Sell |
-20,417
| Closed | -$465K | – | 6660 |
|
|
2020
Q4 | $564K | Buy |
+20,417
| New | +$397K | ﹤0.01% | 4107 |
|
|
2020
Q3 | – | Sell |
-562,994
| Closed | -$10.5M | – | 4951 |
|
|
2020
Q2 | $11.6M | Buy |
+562,994
| New | +$7.66M | 0.02% | 1119 |
|
|
2020
Q1 | – | Sell |
-361,591
| Closed | -$5.61M | – | 4709 |
|
|
2019
Q4 | $5.61M | Buy |
361,591
+313,588
| +653% | +$3.16M | 0.01% | 1838 |
|
|
2019
Q3 | $249K | Sell |
48,003
-482,473
| -91% | -$3.58M | ﹤0.01% | 3662 |
|
|
2019
Q2 | $4.8M | Buy |
530,476
+385,715
| +266% | +$5.75M | 0.01% | 1817 |
|
|
2019
Q1 | $3.46M | Buy |
144,761
+99,487
| +220% | +$2.03M | 0.01% | 2018 |
|
|
2018
Q4 | $743K | Sell |
45,274
-355,089
| -89% | -$7M | ﹤0.01% | 2738 |
|
|
2018
Q3 | $10.6M | Buy |
400,363
+208,927
| +109% | +$4.73M | 0.01% | 1277 |
|
|
2018
Q2 | $4.38M | Buy |
191,436
+84,568
| +79% | +$1.85M | 0.01% | 1898 |
|
|
2018
Q1 | $2.27M | Buy |
106,868
+37,602
| +54% | +$572K | ﹤0.01% | 2237 |
|
|
2017
Q4 | $876K | Sell |
69,266
-30,666
| -31% | -$411K | ﹤0.01% | 2779 |
|
|
2017
Q3 | $1.55M | Sell |
99,932
-32,287
| -24% | -$393K | ﹤0.01% | 2295 |
|
|
2017
Q2 | $1.55M | Buy |
132,219
+105,676
| +398% | +$1.31M | ﹤0.01% | 2225 |
|
|
2017
Q1 | $312K | Buy |
+26,543
| New | +$304K | ﹤0.01% | 3028 |
|
Other funds holding MYOV
Millennium Management's MYOV Position: Q1 2023 in Review
Millennium Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 165,659 shares — an estimated $4.47M sold.
Millennium Management first reported a position in MYOV in Q1 2017 and held it in 21 quarters. The position peaked at $11.6M in Q2 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Millennium Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Millennium Management sold 165,659 Myovant Sciences Ltd. shares in Q1 2023, an estimated $4.47M.
- Millennium Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 21 quarters.
- Millennium Management's Myovant Sciences Ltd. position peaked at $11.6M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.